Illustration Thyca Spirit Items | Thyca: Thyroid Cancer Survivors&#039; Association inside Color Of Thyroid Cancer Ribbon
Byetta and Thyroid Cancer
The type-2 diabetes drug Byetta (exenatide) has been linked to dozens of reports of thyroid cancer. Long-acting exenatide (Bydureon) is known to cause thyroid cancer in rats at normal doses. Our lawyers are concerned that drug-companies are not adequately investigating or warning about the risk of thyroid cancer from Byetta.
Free Byetta Thyroid Cancer Evaluation: If you or your loved one was injured by thyroid cancer from Byetta, contact our law firm immediately for a free case consultation. If you file a lawsuit, you could receive compensation for your injury, medical expenses, and more.
What is Byetta?
Byetta (exenatide) is a once-daily injection drug that is used to improve blood-sugar control in adults with type-2 diabetes. It was developed by Amylin Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in 2005. Byetta was the first FDA-approved drug in the “incretin mimetic” class. These drugs treat diabetes by mimicking hormones that regulate insulin levels.
Byetta Thyroid Cancer
Thyroid cancer occurred in rats given normal doses of exenatide in Bydureon, the extended-release version of Byetta. It is unknown if this risk applies to humans. However, evidence is concerning enough that the FDA placed its strongest warning the “Black Box” on the label for Bydureon.
Byetta has also been linked to thyroid cancer. In 2010, the journal Gastroenterology published a study linking Byetta to a 4.9-fold increased risk of thyroid cancer, based on 30 reports of thyroid cancer between 2004 and 2009. In 2009, the FDA asked Amylin to investigate “a potential signal of a serious risk of thyroid cancer.”
Victoza is another “incretin mimetic” in the same class as Byetta. In 2011, studies prompted a Drug Safety Communication after rats developed thyroid cancer after being given clinically relevant doses of Victoza.
What is the problem?
Drug companies are still investigating the link between Byetta and thyroid cancer. Because thyroid cancer is relatively rare (about 60,000 cases are diagnosed every year) adequate studies could take many years. Experts warn that more studies of all drugs in the “incretin mimetic” class are needed, and caution should be exercised until these studies are complete.
Treatment for Thyroid Cancer
Early diagnosis and treatment for thyroid cancer is essential for a good outcome. Most cases are diagnosed when a person or doctor notices an unusual lump or “nodule” on the neck. Diagnosis requires a biopsy, which is a small tissue sample that is cut out of the neck and studied under a microscope.
Byetta thyroid cancer treatment options may include:
- Surgical excision of thyroid cancer: Alobectomy involves partial surgical removal of the thyroid gland (which is made of two lobes). Total removal of the thyroid gland is called a thyroidectomy, and patients will need to take hormone supplements. If thyroid cancer spreads to the lymph nodes, patients may need to have their lymph nodes removed (lymphadenectomy).
- Radiation and chemotherapy: The thyroid gland absorbs iodine, and treatment withradioactive iodine pills destroys cancerous and non-cancerous cells in the thyroid. If this is not effective, external radiation and/or chemotherapy drugs may be used to kill cancer cells.
Do I have a Byetta Thyroid Cancer Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Byetta lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.